½ÃÀ庸°í¼­
»óǰÄÚµå
1791490

¼¼°èÀÇ Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º ½ÃÀå

Artificial Organs and Bionics

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 129 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º ½ÃÀåÀº 2030³â±îÁö 710¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 432¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 8.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 710¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Àΰø Àå±â´Â CAGR 10.0%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 451¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àΰø ¹ÙÀÌ¿À´Ð½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 6.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 114¾ï ´Þ·¯, Áß±¹Àº CAGR 8.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º ½ÃÀåÀº 2024³â¿¡ 114¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 113¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.3%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 8.1%¿Í 7.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 6.7%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ 'Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º' ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º´Â Àΰ£ÀÇ ¼ö¸í°ú ±â´ÉÀ» ¾î¶»°Ô ÀçÁ¤ÀÇÇϰí Àִ°¡?

Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º´Â Àå±â°¡ °íÀå ³ª°Å³ª ½Åü ±â´ÉÀÌ »ó½ÇµÈ ȯÀڵ鿡°Ô »ý¸íÀ» »ì¸®°í »ý¸íÀ» ¿¬ÀåÇÒ ¼ö ÀÖ´Â ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á Çö´ë ÀÇÇÐÀÇ Àü¸Á¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. Àΰø½ÉÀå, Àΰø½ÅÀåºÎÅÍ Àΰø¿Í¿ì, ¹ÙÀÌ¿À´Ð »çÁö¿¡ À̸£±â±îÁö ÀÌ ºÐ¾ß´Â »ýüÀÇÇаøÇаú ·Îº¿°øÇÐ, ÀüÀÚ°øÇÐ, ÷´Ü¼ÒÀç°¡ À¶ÇÕµÈ ºÐ¾ßÀÔ´Ï´Ù. Àΰø Àå±â´Â À̽ÄÀ» À§ÇÑ Áß¿äÇÑ °¡±³ ¿ªÇÒÀ» Çϸç, Àå±âÀûÀ¸·Î ±âÁõÀÚ ºÎÁ·ÀÌ Áö¼ÓµÉ °æ¿ì Àå±âÀûÀÎ ÇØ°áÃ¥ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÇÑÆí, ¹ÙÀÌ¿À´Ð½º´Â ¿îµ¿, û°¢, ½Ã°¢À» ȸº¹½ÃÄÑ È¯ÀÚÀÇ ÀÚ¸³°ú »îÀÇ Áú ȸº¹À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¸¸¼ºÁúȯÀÌ ¸¸¿¬ÇÑ °í·ÉÈ­ »çȸ¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ½Å°æ ÀÎÅÍÆäÀ̽º, Ã˰¢ Çǵå¹é, ½Ç½Ã°£ ¸ð´ÏÅ͸µÀÇ ÅëÇÕÀ¸·Î Çö´ëÀÇ ¹ÙÀÌ¿À´Ð½º´Â ±× ¾î´À ¶§º¸´Ù ¹ÝÀÀ¼ºÀÌ ¶Ù¾î³ª°í ½ÇÁ¦¿Í À¯»çÇÕ´Ï´Ù. ÇϹݽЏ¶ºñ ȯÀÚÀÇ ÀçȰ°ú À̵¿À» À§ÇÑ ¿Ü°ñ°Ý°ú 3D ÇÁ¸°ÆÃµÈ Àå±â ½ºÄ³Æú´õ´Â ÀÌÀü¿¡´Â ºÒ°¡´ÉÇÏ´Ù°í ¿©°ÜÁ³´ø ÇѰ踦 ¶Ù¾î³Ñ°í ÀÖ½À´Ï´Ù. ¼ÒÇüÈ­, ¹èÅ͸® ¼ö¸í, À̽ÄÇü ¹ÙÀÌ¿À¼¾¼­ µî ²÷ÀÓ¾ø´Â °³¼±À» ÅëÇØ º¸´Ù ½º¸¶Æ®Çϰí ȯÀÚ ¸ÂÃãÇü µð¹ÙÀ̽º°¡ ¸¸µé¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌó·³ ´Ù¾çÇÑ ºÐ¾ßÀÇ À¶ÇÕÀ¸·Î ÇコÄɾî´Â ´õ ÀÌ»ó Àå¾Ö°¡ ¿µ±¸ÀûÀÎ Á¦ÇÑÀÌ ¾Æ´Ñ, Àå±âºÎÀüÀÌ Á×À½ÀÇ ¼±°í°¡ ¾Æ´Ñ ¹Ì·¡¸¦ ÇâÇØ ³ª¾Æ°¡°í ÀÖ½À´Ï´Ù.

ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀ» °¡¼ÓÈ­Çϰí ÀÖ´Â ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡?

Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½ºÀÇ Çõ½ÅÀº Àç»ýÀÇ·á, »ýüÀç·á, AI¸¦ Ȱ¿ëÇÑ Áø´Ü, ·Îº¿°øÇÐÀÇ Çõ½Å¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÇÁ¸°ÆÃ ±â¼úÀ» ÅëÇØ ÀÚ¿¬ Á¶Á÷ÀÇ Æ¯¼ºÀ» ¸ð¹æÇÒ ¼ö ÀÖ´Â ¸Æ°üÀ» °¡Áø Àå±â ±¸Á¶¸¦ ¸¸µé ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Á¶Á÷°øÇÐÀÇ ¹ßÀüÀ¸·Î ÇöÀç´Â ½ÇÇè½Ç¿¡¼­ ¼ºÀå½ÃŲ ÇǺÎ, °¢¸·, ¿¬°ñ±îÁö Àΰø ÀÓÇöõÆ®¿Í ÀÏüȭÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ³ú-±â°è ÀÎÅÍÆäÀ̽º(BMI)¿¡ ÀÇÇØ ±¸µ¿µÇ´Â ½Å°æ ¿¬µ¿ ÀÇÁ·Àº »ç°í¿¡ ÀÇÇÑ Á÷°üÀûÀÎ Á¦¾î¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© Àý´Ü ȯÀÚ³ª ô¼ö ¼Õ»ó ȯÀڵ鿡°Ô »õ·Î¿î °¡´É¼ºÀ» ¿­¾îÁÝ´Ï´Ù. ÀÇÁ·¿¡ ³»ÀåµÈ ¼¾¼­´Â ±×¸³·Â, Ç¥¸é Áú°¨ µî ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇÏ¿© »ç¿ëÀÚ °æÇèÀ» Å©°Ô Çâ»ó½Ãŵ´Ï´Ù. Àΰø½ÉÀå ¹× ½É½Çº¸Á¶ÀåÄ¡(VAD)¿¡¼­´Â ÀÚ±âºÎ»ó½Ä ·ÎÅÍ¿Í ¿¡³ÊÁö È¿À²ÀÌ ³ôÀº ¸ðÅÍ·Î ÀÎÇØ ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í, ÀåÄ¡ÀÇ ¼ö¸íÀÌ ¿¬ÀåµÇ¾ú½À´Ï´Ù. ź¼Ò¼¶À¯ º¹ÇÕÀç¿Í AI ±â¹Ý µ¿ÀÛ ÆÐÅÏ ÀνÄÀ¸·Î ÀÎÇØ µ¿·Â ¿ÜÇǸ¦ Æ÷ÇÔÇÑ ¿þ¾î·¯ºí ¹ÙÀÌ¿À´Ð½º´Â °æ·®È­ ¹× Àú°¡°ÝÈ­°¡ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ³ª³ë ÄÚÆÃ°ú Ç×±Õ Ç¥¸éÀº ÀÓÇöõÆ®ÀÇ »ýüÀûÇÕ¼ºÀ» Çâ»ó½ÃŰ°í °¨¿° À§ÇèÀ» °¨¼Ò½Ãŵ´Ï´Ù. ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÌ ´õ¿í Á¤±³ÇØÁü¿¡ µû¶ó Àν¶¸° ÆßÇÁ, ½É¹ÚÁ¶À²±â, ½ÅÀå º¸Á¶ ÀåÄ¡ µîÀ» µ¿ÀûÀ¸·Î Á¶Á¤ÇÒ ¼ö ÀÖÀ¸¸ç, ÇコÄÉ¾î ¿¹ÃøÀû ÅëÂû·ÂÀ» ÅëÇØ °³ÀÎÈ­µÈ ¼º´ÉÀ» Á¦°øÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.

»çȸÀû, À±¸®Àû, °æÁ¦Àû ¿äÀÎÀÌ ½ÃÀåÀÇ ±Ëµµ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â°¡?

Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º ½ÃÀåÀÌ ¼º¼÷ÇÔ¿¡ µû¶ó ±× ±Ëµµ´Â »çȸÀû ¼ö¿ë, À±¸®Àû ³íÀï, »óȯ Á¤Ã¥¿¡ ÀÇÇØ Á¡Á¡ ´õ ¸¹ÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À´Ð ÆÈ´Ù¸®¿Í Àΰø ÃéÀå ½Ã½ºÅÛÀÇ ¼º°ø »ç·Ê°¡ ÁÖ·ù ¹Ìµð¾î¿¡ µîÀåÇϸ鼭 »çȸÀû ÀνÄÀÌ ÁøÈ­Çϰí ÀÖÁö¸¸, Àΰ£ °­È­, Á¤Ã¼¼º, Á¢±Ù¿¡ ´ëÇÑ À±¸®Àû Àǹ®Àº ¿©ÀüÈ÷ ³²¾ÆÀÖ½À´Ï´Ù. ȸº¹°ú Áõ°¡ÀÇ °æ°è°¡ ¸ðÈ£ÇØÁö¸é¼­, ¹«¾ùÀÌ 'Á¤»ó'ÀÇ °Ç°­ÀÎÁö¿¡ ´ëÇÑ ³íÀǰ¡ Ȱ¹ßÇÏ°Ô ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­´Â ÷´Ü º¸Ã¶¹° ¹× À̽ÄÇü ±â±¸¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¿©ÀüÈ÷ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ ºñ¿ëÀÌ ¿©ÀüÈ÷ Áß¿äÇÑ À庮À¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ±¹°¡ÀÇ ÀǷẸÇèÁ¦µµ´Â ÀÌ·¯ÇÑ °í°¡ÀÇ ±â¼úÀ» ´õ ¸¹ÀÌ º¸ÀåÇØ¾ß ÇÏÁö¸¸, ¿¹»êÀÇ Á¦¾àÀº ¿©ÀüÈ÷ ³²¾Æ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¹ÀâÇÑ ¹ÙÀÌ¿À´Ð ½Ã½ºÅÛ, ƯÈ÷ ÀÌ½Ä ÈÄ ÀçȰÀ» ´Ù·ê ¼ö ÀÖ´Â ÈÆ·ÃµÈ Àü¹®°¡µµ ºÎÁ·ÇÕ´Ï´Ù. Àü ¼¼°è ÀÇ·á °ÝÂ÷´Â ÀÌ·¯ÇÑ ±â¼úÀÌ ¾îµð¿¡, ¾î¶»°Ô äÅõǴÂÁö¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÇÑÆí, ȯÀÚ ¿ËÈ£ ´Üü´Â »ý¸í À¯Áö ÀåÄ¡¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½Å¼ÓÇÑ ½ÂÀÎÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. Á¤ºÎ ¹× NGOÀÇ ¿¬±¸ ÀÚ±Ý Áö¿ø ¹× º¸Á¶±Ý Áö±Þ ³ë·ÂÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖÁö¸¸, ³Î¸® Ȱ¿ëµÉ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀº ¿©ÀüÈ÷ °úÁ¦ÀÔ´Ï´Ù. Çõ½Å¼º, À±¸®¼º, °æÁ¦¼ºÀÇ ±ÕÇüÀ» ¸ÂÃß´Â °ÍÀÌ ÀÌ º¯È­ÀÇ ÀáÀç·ÂÀ» ±Ø´ëÈ­ÇÏ´Â ¿­¼è°¡ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Àΰø Àå±â ¹× ¹ÙÀÌ¿À´Ð½º ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯ ¹× ÅðÇ༺ ÁúȯÀÇ À¯º´·ü Áõ°¡, Àü ¼¼°è Àå±â ±âÁõÀÚ ºÎÁ·, ÀÇ·á ±â¼ú Çõ½Å¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ µîÀÔ´Ï´Ù. ƯÈ÷ À¯·´°ú ÀϺ»ÀÇ °í·ÉÈ­´Â ½ÅÀå ´ëü ¿ä¹ý, ½ÉÇ÷°ü ÀÓÇöõÆ®, º¸Ã»±â ¼ö¿äÀÇ ±ÞÁõ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÌ·¯ÇÑ Àåºñ´Â ´õ¿í Á¤È®Çϰí ÄÄÆÑÆ®ÇØÁ³À¸¸ç, ½Å·Ú¼ºÀÌ ³ô¾ÆÁ® ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµé »çÀÌ¿¡¼­ äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÅÈï±¹¿¡¼­´Â ÇコÄɾî ÀÎÇÁ¶ó°¡ Á¤ºñµÇ°í º¸Çè Àû¿ë ¹üÀ§°¡ È®´ëµÇ°í ÀÖ´Â °ÍÀÌ ½ÃÀå ħÅõ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀçȰ ºÐ¾ß¿¡¼­´Â ÀÇ·á ¹× ±º»ç ºÐ¾ß¿¡¼­ ¿þ¾î·¯ºí ¹ÙÀÌ¿À´Ð ¿Ü°ñ°Ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ Çൿµµ º¯È­Çϰí ÀÖÀ¸¸ç, ȯÀÚµéÀº Á¡Á¡ ´õ ¸¹Àº Á¤º¸¸¦ ¾ò°í ÀÖÀ¸¸ç, ¶óÀÌÇÁ½ºÅ¸Àϰú ÀÚÀ²¼ºÀ» Çâ»ó½ÃŰ´Â ½Åü ÅëÇÕ ±â¼ú äÅÿ¡ ´ëÇØ ±àÁ¤ÀûÀ¸·Î ¹Þ¾ÆµéÀ̰í ÀÖ½À´Ï´Ù. °í¼ÒµæÃþ ½ÃÀå¿¡¼­´Â ¿îµ¿ ´É·ÂÀ̳ª ±â´É °­È­¸¦ À§ÇØ ¼±ÅÃÀûÀ¸·Î ¹ÙÀÌ¿À´Ð ¼Ö·ç¼ÇÀ» »ç¿ëÇÏ´Â »ç·Êµµ µîÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ±â°ü°ú ÇÏÀÌÅ×Å© ±â¾÷°úÀÇ ¿¬±¸ Çù·ÂÀ» ÅëÇØ ½ÃÁ¦Ç° Á¦ÀÛ, Å×½ºÆ®, »óǰȭ¸¦ ºü¸£°Ô ÁøÇàÇϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ¸ðµ¨¿¡¼­´Â Ŭ¶ó¿ìµå ±â¹Ý °Ç°­ µ¥ÀÌÅÍ ÅëÇÕÀÌ °¡´ÉÇϱ⠶§¹®¿¡ ¿ø°Ý ¸ð´ÏÅ͸µ°ú ¿¹Ãø Ä¡·á°¡ °¡´ÉÇϱ⠶§¹®¿¡ ¿ø°Ý ÀÇ·á Ç÷§Æû¿¡ ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú °­·ÂÇÑ Çõ½Å ÆÄÀÌÇÁ¶óÀÎÀÌ µÞ¹ÞħÇÏ´Â ÀÌ·¯ÇÑ Ãß¼¼´Â ½ÃÀåÀÇ »ó½Â ±Ëµµ¸¦ È®°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(Àΰø Àå±â, Àΰø ¹ÙÀÌ¿À´Ð½º);±â¼ú(±â°èÀû ¹ÙÀÌ¿À´Ð½º ±â¼ú, ÀüÀÚ ¹ÙÀÌ¿À´Ð½º ±â¼ú)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB(Getinge Group)
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå°ú °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦4Àå °æÀï

LSH

Global Artificial Organs and Bionics Market to Reach US$71.0 Billion by 2030

The global market for Artificial Organs and Bionics estimated at US$43.2 Billion in the year 2024, is expected to reach US$71.0 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Artificial Organs, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$45.1 Billion by the end of the analysis period. Growth in the Artificial Bionics segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 8.3% CAGR

The Artificial Organs and Bionics market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global "Artificial Organs And Bionics" Market - Key Trends & Drivers Summarized

How Are Artificial Organs And Bionics Redefining Human Longevity And Functionality?

Artificial organs and bionics are revolutionizing the landscape of modern medicine by offering life-saving and life-enhancing alternatives for patients with failing organs or lost bodily functions. From artificial hearts and kidneys to cochlear implants and bionic limbs, this sector merges biomedical engineering with robotics, electronics, and advanced materials. Artificial organs serve as vital bridges to transplants or long-term solutions where donor shortages persist. Bionics, meanwhile, restore movement, hearing, or vision-enabling patients to regain independence and quality of life. These innovations are especially critical for aging populations, where chronic diseases are prevalent. The integration of neural interfaces, haptic feedback, and real-time monitoring has made modern bionics more responsive and lifelike than ever before. Exoskeletons for rehabilitation and mobility in paraplegic patients, as well as 3D-printed organ scaffolds, are pushing boundaries previously thought impossible. Continuous improvement in miniaturization, battery life, and implantable biosensors is creating smarter, more patient-adaptive devices. This convergence of disciplines is moving healthcare toward a future where disability is no longer a permanent limitation, and organ failure no longer a death sentence.

What Technological Breakthroughs Are Accelerating Innovation In This Field?

Innovation in artificial organs and bionics is being propelled by breakthroughs in regenerative medicine, biomaterials, AI-enabled diagnostics, and robotics. Bio-printing technologies are enabling the creation of vascularized organ structures that can mimic natural tissue properties. Advances in tissue engineering now allow lab-grown skin, corneas, and even cartilage to be integrated with synthetic implants. Neural-linked prosthetics, driven by brain-machine interfaces (BMIs), enable intuitive control through thought, opening new possibilities for amputees and spinal cord injury patients. Sensors embedded in prosthetic limbs provide real-time feedback, such as grip strength or surface texture, which significantly improves user experience. In artificial hearts and ventricular assist devices (VADs), magnetically levitated rotors and energy-efficient motors have enhanced safety and extended device longevity. Wearable bionics, including powered exosuits, are becoming lighter and more affordable thanks to carbon fiber composites and AI-based motion pattern recognition. Nanocoatings and antimicrobial surfaces are improving the biocompatibility of implants, reducing infection risks. As machine learning algorithms become more sophisticated, they are enabling dynamic adjustments in insulin pumps, pacemakers, and renal assist devices, offering personalized performance with predictive healthcare insights.

Are Societal, Ethical, And Economic Factors Influencing Market Trajectory?

As the artificial organ and bionics market matures, its trajectory is increasingly shaped by social acceptance, ethical debates, and reimbursement policies. Public perception is evolving as success stories of bionic limbs or artificial pancreas systems enter mainstream media, but ethical questions about human enhancement, identity, and access remain. The line between restoration and augmentation is blurring, leading to debates on what constitutes “normal” health. Cost remains a critical barrier, especially in developing regions, where access to advanced prosthetics and implantable devices is still limited. Health insurance systems in many countries are under pressure to cover more of these expensive technologies, yet budget constraints remain. There’s also a shortage of trained professionals to handle complex bionic systems, particularly in post-implantation rehabilitation. Global health disparities are influencing where and how these technologies are adopted. Meanwhile, patient advocacy groups are demanding faster regulatory approvals for life-saving devices. Efforts by governments and NGOs to fund research and offer subsidies are gaining momentum, but widespread accessibility remains a challenge. Balancing innovation, ethics, and affordability will be key to unlocking the full potential of this transformative sector.

The Growth In The Artificial Organs And Bionics Market Is Driven By Several Factors…

…including the rising prevalence of chronic and degenerative diseases, the global shortage of organ donors, and increasing investments in medical innovation. The aging global population, particularly in Europe and Japan, is contributing to a surge in demand for renal replacement therapies, cardiovascular implants, and hearing aids. Technological readiness has made these devices more accurate, compact, and reliable, encouraging adoption among healthcare providers. In emerging economies, rising healthcare infrastructure and growing insurance coverage are facilitating market penetration. The rehabilitation sector is expanding with demand for wearable bionic exoskeletons in both medical and military settings. Consumer behavior is shifting, too-patients are increasingly informed and open to adopting body-integrated technologies that enhance lifestyle and autonomy. In high-income markets, elective use of bionic solutions for athletic performance or functional enhancement is also emerging. Research collaborations between medical institutions and tech firms are leading to faster prototyping, testing, and commercialization. The availability of cloud-based health data integration in newer models allows remote monitoring and predictive care, which is particularly attractive to telemedicine platforms. These trends, underpinned by regulatory support and a strong innovation pipeline, are solidifying the market’s upward trajectory.

SCOPE OF STUDY:

The report analyzes the Artificial Organs and Bionics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Artificial Organs, Artificial Bionics); Technology (Mechanical Bionics Technology, Electronic Bionics Technology)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Berlin Heart GmbH
  • Bornlife Prosthetic and Orthotic Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics Holdings Inc.
  • Getinge AB (Getinge Group)
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • Ossur
  • Sonova
  • SynCardia Systems, LLC
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Organs and Bionics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Organ Failure Cases Drive Demand for Artificial Organs
    • Technological Innovations in Bionic Limbs Improve Mobility and Quality of Life
    • Increased Investment in 3D Bioprinting of Tissues Accelerates Market Expansion
    • Growing Use of Neural Interfaces in Bionics Enhances Functional Capabilities
    • Shortage of Organ Donors Boosts Development of Artificial Alternatives
    • Surging Demand for Wearable and Implantable Health Devices Fuels Bionic Integration
    • Advancements in Smart Prosthetics Offer Customization and Real-Time Feedback
    • Expanding Application in Military and Rehabilitation Drives Innovation
    • Insurance Coverage for Artificial Organs Encourages Patient Adoption
    • Emergence of Soft Robotics in Artificial Organ Development Improves Biocompatibility
    • AI-Driven Control Systems in Bionics Enhance Patient Outcomes
    • Growing Geriatric Population with Chronic Organ Diseases Supports Long-Term Growth
    • Cross-Sector Collaborations in Biotech and Engineering Foster Breakthroughs
    • Global Expansion of Transplant Centers and Medical Facilities Drives Market Reach
    • Increased Funding from Government and Private Institutions Spurs R&D Progress
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Organs and Bionics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Artificial Bionics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Artificial Bionics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mechanical Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Mechanical Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Electronic Bionics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Electronic Bionics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 13: USA 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 17: Canada 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Canada 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • JAPAN
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Japan 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • CHINA
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 24: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: China 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • EUROPE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: Europe 6-Year Perspective for Artificial Organs and Bionics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • FRANCE
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 34: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: France 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: France 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • GERMANY
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Germany 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Italy 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 46: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: UK 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: UK 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Organs and Bionics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Product Type - Artificial Organs and Artificial Bionics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Product Type - Percentage Breakdown of Value Sales for Artificial Organs and Artificial Bionics for the Years 2025 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Artificial Organs and Bionics by Technology - Mechanical Bionics Technology and Electronic Bionics Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of World 6-Year Perspective for Artificial Organs and Bionics by Technology - Percentage Breakdown of Value Sales for Mechanical Bionics Technology and Electronic Bionics Technology for the Years 2025 & 2030

IV. COMPETITION

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦